Abstract
BackgroundTapering and stopping DMARD treatment attracts growing interest due to the steady increase in rheumatoid arthritis (RA) patients achieving sustained disease remission. Since only a subset of RA patients in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
